QCG
MED icon

Quadrant Capital Group’s Medifast MED Stock Holding History

Quadrant Capital Group’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-249
Closed -$5.43K – 2777
2024
Q2 		$5.43K Sell
249
-1,302
-84% -$34.7K ﹤0.01% 2274
2024
Q1 		$59.4K Buy
1,551
+1,460
+1,604% +$70.7K ﹤0.01% 1293
2023
Q4 		$6.12K Sell
91
-183
-67% -$12.7K ﹤0.01% 2213
2023
Q3 		$20.5K Sell
274
-15
-5% -$1.33K ﹤0.01% 1700
2023
Q2 		$26.6K Buy
289
+233
+416% +$20.7K ﹤0.01% 1580
2023
Q1 		$5.81K Sell
56
-123
-69% -$13.6K ﹤0.01% 2194
2022
Q4 		$20.6K Sell
179
-28
-14% -$3.26K ﹤0.01% 1641
2022
Q3 		$22K Buy
207
+188
+989% +$26.9K ﹤0.01% 1485
2022
Q2 		$3K Buy
19
+10
+111% +$1.79K ﹤0.01% 2122
2022
Q1 		$2K Hold
9
– – ﹤0.01% 2163
2021
Q4 		$2K Hold
9
– – ﹤0.01% 2154
2021
Q3 		$2K Hold
9
– – ﹤0.01% 2163
2021
Q2 		$3K Hold
9
– – ﹤0.01% 2011
2021
Q1 		$2K Hold
9
– – ﹤0.01% 2087
2020
Q4 		$2K Hold
9
– – ﹤0.01% 1966
2020
Q3 		$1K Hold
9
– – ﹤0.01% 2013
2020
Q2 		$1K Hold
9
– – ﹤0.01% 2088
2020
Q1 		$1K Sell
9
-236
-96% -$21.5K ﹤0.01% 2013
2019
Q4 		$26K Buy
+245
New +$23.7K ﹤0.01% 1623

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quadrant Capital Group's MED Position: Q3 2024 in Review

Quadrant Capital Group sold out of Medifast (MED) in Q3 2024, closing a stake of 249 shares — an estimated $5.43K sold.

Quadrant Capital Group first reported a position in MED in Q4 2019 and held it in 19 quarters. The position peaked at $59.4K in Q1 2024. 140 funds tracked by Wall St. Rank hold MED as of Q3 2024.

  • Quadrant Capital Group reported no remaining Medifast position as of Q3 2024 after selling out during the quarter.
  • Quadrant Capital Group sold 249 Medifast shares in Q3 2024, an estimated $5.43K.
  • Quadrant Capital Group first reported a position in Medifast in Q4 2019 and held it in 19 quarters.
  • Quadrant Capital Group's Medifast position peaked at $59.4K in Q1 2024.
  • 140 funds tracked by Wall St. Rank held Medifast as of Q3 2024.

Based on Quadrant Capital Group's 13F filing for Q3 2024, filed 12 Nov 2024.